KalVista Pharmaceuticals Statistics

Total Valuation

KALV has a market cap or net worth of $985.52 million. The enterprise value is $969.00 million.

Market Cap	985.52M
Enterprise Value	969.00M

Important Dates

The next estimated earnings date is Thursday, July 9, 2026, before market open.

Earnings Date	Jul 9, 2026
Ex-Dividend Date	n/a

Share Statistics

KALV has 51.22 million shares outstanding. The number of shares has increased by 12.33% in one year.

Current Share Class	51.22M
Shares Outstanding	51.22M
Shares Change (YoY)	+12.33%
Shares Change (QoQ)	+2.42%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	92.33%
Float	29.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.38
Forward PS	5.44
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.58

Current Ratio	5.58
Quick Ratio	5.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-59.81%
Weighted Average Cost of Capital (WACC)	2.80%
Revenue Per Employee	$267,698
Profits Per Employee	-$597,404
Employee Count	275
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.11% in the last 52 weeks. The beta is -0.40, so KALV's price volatility has been lower than the market average.

Beta (5Y)	-0.40
52-Week Price Change	+48.11%
50-Day Moving Average	17.91
200-Day Moving Average	14.90
Relative Strength Index (RSI)	50.95
Average Volume (20 Days)	1,113,625

Short Selling Information

The latest short interest is 19.65 million, so 38.35% of the outstanding shares have been sold short.

Short Interest	19.65M
Short Previous Month	20.36M
Short % of Shares Out	38.35%
Short % of Float	66.52%
Short Ratio (days to cover)	17.13

Income Statement

In the last 12 months, KALV had revenue of $73.62 million and -$164.29 million in losses. Loss per share was -$3.05.

Revenue	73.62M
Gross Profit	18.94M
Operating Income	-166.27M
Pretax Income	-165.84M
Net Income	-164.29M
EBITDA	-164.82M
EBIT	-166.27M
Loss Per Share	-$3.05

Full Income Statement

Balance Sheet

The company has $300.21 million in cash and $284.21 million in debt, giving a net cash position of $16.01 million or $0.31 per share.

Cash & Cash Equivalents	300.21M
Total Debt	284.21M
Net Cash	16.01M
Net Cash Per Share	$0.31
Equity (Book Value)	-2.71M
Book Value Per Share	-0.05
Working Capital	262.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$122.43 million and capital expenditures -$2.56 million, giving a free cash flow of -$124.99 million.

Operating Cash Flow	-122.43M
Capital Expenditures	-2.56M
Depreciation & Amortization	1.45M
Net Borrowing	208.57M
Free Cash Flow	-124.99M
FCF Per Share	-$2.44

Full Cash Flow Statement

Margins

Gross margin is 25.73%, with operating and profit margins of -225.86% and -223.16%.

Gross Margin	25.73%
Operating Margin	-225.86%
Pretax Margin	-225.27%
Profit Margin	-223.16%
EBITDA Margin	-223.88%
EBIT Margin	-225.86%
FCF Margin	n/a

Dividends & Yields

KALV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.33%
Shareholder Yield	-12.33%
Earnings Yield	-16.68%
FCF Yield	-12.69%

Analyst Forecast

The average price target for KALV is $32.60, which is 69.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.60
Price Target Difference	69.44%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	33.98%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KALV has an Altman Z-Score of -2.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.56
Piotroski F-Score	1